Seasoned investor and operator focused on early-stage technology and healthcare companies, with experience sourcing, diligencing and scaling ventures across product and go-to-market functions. Emma M. Wyman combines hands-on startup operating roles with investor-facing responsibilities, advising boards, structuring seed and Series A rounds and supporting portfolio growth. Market-facing strengths include strategic partnerships, financial planning and recruiting senior management.
Seasoned investor and operator focused on early-stage technology and healthcare companies, with experience sourcing, diligencing and scaling ventures across product and go-to-market functions. Emma M. Wyman combines hands-on startup operating roles with investor-facing responsibilities, advising boards, structuring seed and Series A rounds and supporting portfolio growth. Market-facing strengths include strategic partnerships, financial planning and recruiting senior management.
Combines operator instincts with venture discipline, targeting early-stage technology and healthcare companies where product-market fit is nascent and go-to-market scale is attainable. Prefers seed to Series A capital deployment, co-investing in founder-led teams and structuring rounds to retain optionality. Emphasizes rigorous due diligence on unit economics, strategic partnership potential and leadership hiring, favors concentrated, active portfolio construction with 3–7 year horizon and pragmatic risk control.
Combines operator instincts with venture discipline, targeting early-stage technology and healthcare companies where product-market fit is nascent and go-to-market scale is attainable. Prefers seed to Series A capital deployment, co-investing in founder-led teams and structuring rounds to retain optionality. Emphasizes rigorous due diligence on unit economics, strategic partnership potential and leadership hiring, favors concentrated, active portfolio construction with 3–7 year horizon and pragmatic risk control.
| Trades 814 | Longs Won 431/814 52% | Profit Factor 8.82 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $925,095.55 |
| Average Win $196,422.37 | Best Trade (Jul 16) $16.81M | Sharpe Ratio -9.09 |
| Average Loss -$25,068.42 | Worst Trade (Jul 16) -$1.32M | Z-Score -13.66 (100%) |
| Commissions $0 | Avg. Trade Length 12m 3d | Expectancy $92,207.41 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 1.21% |
| Consecutive Losing Trades | 7,752 | 6,977 | 6,202 | 5,426 | 4,651 | 3,876 | 3,101 | 2,326 | 1,550 | 775 |